Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

A KLF4-DYRK2-mediated pathway regulating self-renewal in CML stem cells.

Park CS, Lewis AH, Chen TJ, Bridges CS, Shen Y, Suppipat K, Puppi M, Tomolonis JA, Pang PD, Mistretta TA, Ma L, Green MR, Rau R, Lacorazza HD.

Blood. 2019 Nov 28;134(22):1960-1972. doi: 10.1182/blood.2018875922.

PMID:
31515251
2.

Inactivation of KLF4 promotes T-cell acute lymphoblastic leukemia and activates the MAP2K7 pathway.

Shen Y, Park CS, Suppipat K, Mistretta TA, Puppi M, Horton TM, Rabin K, Gray NS, Meijerink JPP, Lacorazza HD.

Leukemia. 2017 Jun;31(6):1314-1324. doi: 10.1038/leu.2016.339. Epub 2016 Nov 22.

PMID:
27872496
3.

NUDT15 c.415C>T increases risk of 6-mercaptopurine induced myelosuppression during maintenance therapy in children with acute lymphoblastic leukemia.

Chiengthong K, Ittiwut C, Muensri S, Sophonphan J, Sosothikul D, Seksan P, Suppipat K, Suphapeetiporn K, Shotelersuk V.

Haematologica. 2016 Jan;101(1):e24-6. doi: 10.3324/haematol.2015.134775. Epub 2015 Sep 24. No abstract available.

4.

Redefining clinical risk classification in children with precursor B cell acute lymphoblastic leukemia using pre-treatment absolute lymphocyte count.

Fungpipat P, Sophonphan J, Sosothikul D, Suppipat K.

Leuk Lymphoma. 2016;57(4):953-6. doi: 10.3109/10428194.2015.1081194. Epub 2015 Oct 12. No abstract available.

PMID:
26292611
5.

From the Table to the Bedside: Can Food-Derived Sulforaphane be used as a Novel Agent to Treat Leukemia?

Suppipat K, Lacorazza HD.

Curr Cancer Drug Targets. 2014;14(5):434-45. Review.

PMID:
24861849
6.

Sulforaphane induces cell cycle arrest and apoptosis in acute lymphoblastic leukemia cells.

Suppipat K, Park CS, Shen Y, Zhu X, Lacorazza HD.

PLoS One. 2012;7(12):e51251. doi: 10.1371/journal.pone.0051251. Epub 2012 Dec 12.

Supplemental Content

Loading ...
Support Center